Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.

[1]  J. Bystryn,et al.  Characterization of vitiligo antigens. , 1995, Pigment cell research.

[2]  S. Im,et al.  The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients. , 1993, Journal of dermatological science.

[3]  S. Im,et al.  Increased Incidence of Antismooth Muscle Antibody in Korean Vitiligo Patients , 1993, The Journal of dermatology.

[4]  J. Bystryn,et al.  Cytolytic antibodies to melanocytes in vitiligo. , 1993, The Journal of investigative dermatology.

[5]  S. Im,et al.  PERIPHERAL BLOOD LYMPHOCYTE IMBALANCE IN KOREANS WITH ACTIVE VITILIGO , 1993, International journal of dermatology.

[6]  S. Im,et al.  Culture of melanocytes obtained from normal and vitiligo subjects. , 1992, Yonsei medical journal.

[7]  J. Bystryn,et al.  Identification of pigment cell antigens defined by vitiligo antibodies. , 1992, The Journal of investigative dermatology.

[8]  J. Bystryn,et al.  Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. , 1991, The Journal of investigative dermatology.

[9]  J. Bystryn,et al.  Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. , 1988, The Journal of investigative dermatology.

[10]  G. Naughton,et al.  Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. , 1986, Journal of the American Academy of Dermatology.

[11]  G. Naughton,et al.  THE SIGNIFICANCE OF VITILIGO ANTIBODIES , 1985, The Journal of dermatology.

[12]  D. Doniach,et al.  ANTIBODIES TO MELANOCYTES IN VITIUGO , 1984, The Lancet.

[13]  G. Naughton,et al.  Antibodies to normal human melanocytes in vitiligo , 1983, The Journal of experimental medicine.

[14]  R. Morris,et al.  Failure to demonstrate a role for line Ib tumor-associated surface antigen in the etiology of age-dependent polioencephalomyelitis. , 1982, Molecular immunology.

[15]  M. Eisinger,et al.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Nordlund,et al.  Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis. , 1981, Archives of dermatology.

[17]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Katz,et al.  Autoimmune vitiligo: detection of antibodies to melanin-producing cells. , 1977, The New England journal of medicine.

[19]  H. Katz,et al.  Vitiligo and multiple glandular insufficiencies. , 1972, JAMA.

[20]  A. Lerner.  On the etiology of vitiligo and gray hair. , 1971, The American journal of medicine.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  R. Dawber,et al.  VITILIGO IN MATURE‐ONSET DIABETES MELLITUS , 1968, The British journal of dermatology.

[23]  C. J. Stevenson,et al.  VITILIGO, THYROID DISEASE AND AUTOIMMUNITY , 1968, The British journal of dermatology.